3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Melanoma
1
Hepatitis
1
Colitis
1
Interventions
Specimen Handling
123
Magnetic Resonance Spectroscopy
99
Biopsy
72
pembrolizumab
58
Carboplatin
55
Nivolumab
54
Cisplatin
53
Cyclophosphamide
51
Paclitaxel
41
Bevacizumab
36
Radiotherapy
33
Gemcitabine
33
Dexamethasone
30
Doxorubicin
25
atezolizumab
24
Fluorouracil
24
olaparib
23
Rituximab
23
Pemetrexed
23
fludarabine
22
durvalumab
21
Radiation
21
Cytarabine
21
venetoclax
20
Vincristine
20
Prednisone
20
Oxaliplatin
20
Ipilimumab
20
Injections
20
Lenalidomide
19
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Methoxsalen
×
30 days
×
Clear all
NCT07619898
2026-06-02
PHOENIX-ECP
Therakos LLC
Phase 2
Not yet recruiting
112 enrolled